Tildrakizumab effective and safe therapy for patients with psoriasis: Study
A recent comprehensive study unveiled the real-world evidence of the effectiveness and safety of a biological drug, tildrakizumab, in treating patients with moderate-to-severe psoriasis. The key highlights of this study were published in the recent edition of Drugs in Context journal. This multicentric, prospective, observational study marks a significant stride forward to help understand the treatments […]